Sung Receives Young Investigator Translational Research Skills Development Award
June 13, 2013
Anthony Sung, M.D. recently received the Young Investigator Translational Research Skills Development Award from the Center for Thrombotic and Hemostatic Disorders. Sung is a second-year hematology/oncology fellow at Duke University Medical Center. His research focuses on preclinical studies of a novel fibrinogen-coated nanosphere for the treatment of thrombocytopenia. The goal of his study is to establish the safety and efficacy of these nanospheres in murine models of thrombocytopenia and to elucidate the interactions between fibrinogen-coated nanospheres and primary and secondary hemostatic pathways.
This award will allow Sung to continue his research and establish the experience and background necessary for his promising future in independent investigation. He will be mentored by Thomas Ortel, M.D., Ph.D., and Nelson Chao, M.D., M.B.A.
The Center for Thrombotic and Hemostatic Disorders was established by a grant from the National Heart, Lung, and Blood Institute. It is a project supported by the Duke Translational Research Institute and it is part of a national consortium dedicated to this research.